p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glaucoma is an age-related neurodegenerative disease of retinal ganglion cells, and appropriate turnover of the extracellular matrix in the trabecular meshwork is important in its pathology. Here, we report the effects of Rho-associated kinase (ROCK) and p38 MAP kinase on transforming growth factor (TGF)-β2-induced type I collagen production in human trabecular meshwork cells. TGF-β2 increased RhoA activity, actin polymerization, and myosin light chain 2 phosphorylation. These effects were significantly inhibited by Y-27632, but not SB203580. TGF-β2 also increased promoter activity, mRNA synthesis, and protein expression of COL1A2. These effects were significantly inhibited by SB203580, but not Y-27632. Additionally, Y-27632 did not significantly inhibit TGF-β2-induced promoter activation, or phosphorylation or nuclear translocation of Smad2/3, whereas SB203580 partially suppressed these processes. Collectively, TGF-β2-induced production of type 1 collagen is suppressed by p38 inhibition and accompanied by partial inactivation of Smad2/3, in human trabecular meshwork cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Collagen Type I upregulation has been shown to be suppressed by the p38 inhibitor SB203580 [ 118 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Retinal nerve fiber layer analysis in the diagnosis of glaucoma
Zangwill, L. M., & Bowd, C. (2006) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000193079.55240.18 · Cited by 595
Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2
Tripathi, R. C., Li, J., Chan, W. A., & Tripathi, B. J. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1158 · Cited by 566
ARMALY, M. F. (1963) · Archives of Ophthalmology · doi:10.1001/archopht.1963.00960050484010 · Cited by 553 · cited 1×
“Armaly reported that the glucocorticoid dexamethasone (DEX) induces changes in IOP and fluid dynamics more frequently in glaucomatous than in normal eyes [33], [34].”
BackgroundExtracellular matrix in the trabecular meshwork
Acott, T. S., & Kelley, M. J. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.013 · Cited by 503 · cited 1×
“In this pathway, appropriate turnover of the extracellular matrix (ECM) in the TM is essential for maintaining normal outflow; excessive deposition of ECM increases the resistance to aqueous outflow [3], [4].”
BackgroundModulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao, P., Pf, D., Kumar, J., & Dl, E. (2001) · PubMed · Cited by 422
Honjo, M., Tanihara, H., Inatani, M., Kido, N., Sawamura, T., Yue, B. Y., Narumiya, S., & Honda, Y. (2001) · PubMed · Cited by 385
Self-citationTransforming growth factor-β2 levels in aqueous humor of glaucomatous eyes
Inatani, M., Tanihara, H., Katsuta, H., Honjo, M., Kido, N., & Honda, Y. (2001) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170000241 · Cited by 270
Self-citationEffects of TGF- 2 in Perfused Human Eyes
Gottanka, J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0796 · Cited by 260 · cited 1×
“TGF-β2 increases the resistance in the aqueous humor outflow, via a mechanism involving deposition of ECM, including type 1 collagen, through changes in the actin cytoskeleton in the TM [5], [6], [7], [8], [9].”
BackgroundARMALY, M. F. (1963) · Archives of Ophthalmology · doi:10.1001/archopht.1963.00960050494011 · Cited by 250 · cited 1×
“Armaly reported that the glucocorticoid dexamethasone (DEX) induces changes in IOP and fluid dynamics more frequently in glaucomatous than in normal eyes [33], [34].”
BackgroundTakai, Y., Tanito, M., & Ohira, A. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8434 · Cited by 233
Tanihara, H., Inoue, T., Yamamoto, T., Kuwayama, Y., Abe, H., & Araie, M. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.05.016 · Cited by 190
Self-citationMechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells
Pattabiraman, P. P., & Rao, P. V. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2009 · Cited by 189
The extracellular matrix and its modulation in the trabecular meshwork
Weinreb, R., Cotlier, E., & Yue, B. Y. J. T. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80066-x · Cited by 168 · cited 1×
“In this pathway, appropriate turnover of the extracellular matrix (ECM) in the TM is essential for maintaining normal outflow; excessive deposition of ECM increases the resistance to aqueous outflow [3], [4].”
BackgroundTanihara, H. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.76 · Cited by 163 · cited 1×
“Intriguingly, several recent clinical studies have demonstrated the IOP-lowering effect of ROCK inhibition in normal volunteers and glaucoma patients [15], [16], [17], [18], [19], and one of the drugs, Ripasudil was approved in Japan as an IOP-lowering drug.”
BackgroundSelf-citationChen, S., Crawford, M., Day, R. M., Briones, V. R., Leader, J. E., Jose, P. A., & Lechleider, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507771200 · Cited by 145 · cited 1×
“Inactivation of the Rho-ROCK signaling pathway suppresses the canonical TGF-β pathway in some cell types, such as retinal epithelial cells, smooth muscle cells, and mesenchymal stem cells [22], [29], [30].”
BackgroundPattabiraman, P. P., Maddala, R., & Rao, P. V. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24524 · Cited by 138 · cited 1×
“In human TM cells, there is reportedly a link between Rho GTPase and TGF-β2 signaling pathways [24].”
BackgroundWilliams, R. D., Novack, G. D., van Haarlem, T., & Kopczynski, C. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.04.012 · Cited by 131
Junglas, B., Yu, A. H. L., Welge‐Lüßen, U., Tamm, E. R., & Fuchshofer, R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.008 · Cited by 123 · cited 1×
“TGF-β2 increases the resistance in the aqueous humor outflow, via a mechanism involving deposition of ECM, including type 1 collagen, through changes in the actin cytoskeleton in the TM [5], [6], [7], [8], [9].”
BackgroundPhase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115
Tanihara, H. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.323 · Cited by 118
Self-citationRecent developments in understanding the pathophysiology of elevated intraocular pressure
Tan, J. C. H., Peters, D. M. P., & Kaufman, P. L. (2006) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0001276636.26419.18 · Cited by 112 · cited 1×
“Increased resistance in the conventional aqueous humor outflow pathway is a major cause of elevated IOP in glaucoma patients [2].”
BackgroundMihira, H., Suzuki, H. I., Akatsu, Y., Yoshimatsu, Y., Igarashi, T., Miyazono, K., & Watabe, T. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvr121 · Cited by 107 · cited 1×
“Interestingly, previous studies reported that TGF-β–induced Rho activation was Smad-dependent in some cells [31], [32].”
BackgroundKimoto, K., Nakatsuka, K., Matsuo, N., & Yoshioka, H. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1276 · Cited by 82 · cited 1×
“Plasmid constructs used in these experiments were described previously [21], [22] HTM cells were seeded the day before transfection in 6- or 12-well plates.”
MethodSelf-citationElasticity-Dependent Modulation of TGF-β Responses in Human Trabecular Meshwork Cells
Han, H., Wecker, T., Grehn, F., & Schlunck, G. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6640 · Cited by 79 · cited 1×
“TGF-β2 increases the resistance in the aqueous humor outflow, via a mechanism involving deposition of ECM, including type 1 collagen, through changes in the actin cytoskeleton in the TM [5], [6], [7], [8], [9].”
BackgroundNakamura, Y., Hirano, S., 鈴木, 克., Seki, K., Sagara, T., & Nishida, T. (2002) · PubMed · Cited by 70
Xu, T., Wu, M., Feng, J., Lin, X., & Gu, Z. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1107 · Cited by 68 · cited 1×
“Inactivation of the Rho-ROCK signaling pathway suppresses the canonical TGF-β pathway in some cell types, such as retinal epithelial cells, smooth muscle cells, and mesenchymal stem cells [22], [29], [30].”
BackgroundFujimoto, T., Inoue, T., Kameda, T., Kasaoka, N., Inoue-Mochita, M., Tsuboi, N., & Tanihara, H. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9989 · Cited by 67 · cited 2×
“We reported previously that DEX also activates RhoA in HTM cells and that the induction of fibronectin and COL4A1mRNAs are inhibited by Y-27632 [20].”
BackgroundSelf-citationItoh, Y., Kimoto, K., Imaizumi, M., & Nakatsuka, K. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.10.017 · Cited by 64 · cited 2×
“Inactivation of the Rho-ROCK signaling pathway suppresses the canonical TGF-β pathway in some cell types, such as retinal epithelial cells, smooth muscle cells, and mesenchymal stem cells [22], [29], [30].”
BackgroundMethodSelf-citationLee, J., Moon, H.-J., Lee, J. M., & Joo, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073155 · Cited by 63 · cited 1×
“Interestingly, previous studies reported that TGF-β–induced Rho activation was Smad-dependent in some cells [31], [32].”
BackgroundFukushima, M., Nakamuta, M., Kohjima, M., Kotoh, K., Enjoji, M., Kobayashi, N., & Nawata, H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01142.x · Cited by 60 · cited 2×
“Among them, the biochemical blockade of p38 MAP kinase activation, but not ERK activation, inhibits TGF-β2–induced type I collagen synthesis in retinal epithelial cells [25].”
BackgroundRegulation of SPARC by Transforming Growth Factor β2 in Human Trabecular Meshwork
Kang, M. H., Oh, D.-J., Kang, J.-H., & Rhee, D. J. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-11474 · Cited by 41 · cited 1×
“Similarly, it is reported that TGF-β2–induced expression of secreted protein acidic and rich in cysteine (SPARC) is suppressed by the inhibition of p38 in HTM cells [27].”
BackgroundSethi, A., Wordinger, R. J., & Clark, A. F. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.05.011 · Cited by 37 · cited 1×
“showed that gremlin, a BMP inhibitor, activates TGF-β signaling and thereby induces lysyl oxidase genes in HTM cells [28].”
BackgroundKopczynski, C., Novack, G. D., Swearingen, D., & van Haarlem, T. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302466 · Cited by 30 · cited 1×
“Intriguingly, several recent clinical studies have demonstrated the IOP-lowering effect of ROCK inhibition in normal volunteers and glaucoma patients [15], [16], [17], [18], [19], and one of the drugs, Ripasudil was approved in Japan as an IOP-lowering drug.”
BackgroundBanghong, D., Yang, C., Houren, W., Zhi-xin, C., Yinbo, S., & Li, Z. (2004) · Current Medical Science · doi:10.1007/bf02831117 · Cited by 8 · cited 1×
“TGF-β2 increases the resistance in the aqueous humor outflow, via a mechanism involving deposition of ECM, including type 1 collagen, through changes in the actin cytoskeleton in the TM [5], [6], [7], [8], [9].”
Background
Cited by
Luo, L.-J., Nguyen, D. D., & Lai, J.-Y. (2021) · Theranostics · doi:10.7150/thno.54525 · Cited by 106
“Considering that TGF-β is a key modulator in altering the actin cytoskeleton of TM cells [51], we employed this growth factor to stimulate actin changes in TM cells and to investigate their response to Y-27632-loaded HMCNs with different shell”
BackgroundMethodTsai, C., Wu, S., Kau, H., & Wei, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-25370-3 · Cited by 82
Zhavoronkov, A. A., Izumchenko, E., Kanherkar, R. R., Teka, M., Cantor, C. R., Manaye, K. F., Sidransky, D., West, M. D., Makarev, E., & Csoka, A. B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170261 · Cited by 70
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Similarly, p38 has been reported to mediate the expression of extracellular matrix-related proteins in TGF-β stimulated TMCs. Collagen Type I upregulation has been shown to be suppressed by the p38 inhibitor SB203580 [118].”
BackgroundInfluentialLi, G., Lee, C.-Y., Read, A. T., Wang, K., Ha, J., Kuhn, M. N., Navarro, I. D., Cui, J., Young, K., Gorijavolu, R., et al. (2021) · eLife · doi:10.7554/elife.60831 · Cited by 65
Metadata
- Authors
- Inoue-Mochita, M., Inoue, T., Fujimoto, T., Kameda, T., Awai-Kasaoka, N., Ohtsu, N., Kimoto, K., & Tanihara, H.
- Affiliations
- Kumamoto University (JP)
- Kyoto University (JP)
- Oita University (JP)
- Corresponding author
- Inoue, Toshihiro
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-23
- Volume
- 10
- Issue
- 3
- Pages
- e0120774
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4370581
- OpenAlex
- W2135038084
- Cited by
- 34
- References
- 34
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 8 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (25861640, 23390403, 23791994)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p38 MAPK, Rho kinase, TGF-beta2, type I collagen, trabecular meshwork cells, glaucoma, extracellular matrix turnover, RhoA, actin polymerization, myosin light chain 2 phosphorylation, Smad2/3, COL1A2, Y-27632, SB203580
- MeSH terms
- Cell Line, Humans, Phosphorylation, Protein Binding, Trabecular Meshwork, Signal Transduction, Myosin Light Chains, Collagen Type I, Cardiac Myosins, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Smad Proteins, Transforming Growth Factor beta2, rho-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.